According to a recent study titled ‘USA Genome Sequencing Market Analysis, 2020’, available with Market Study Report, USA genome sequencing market is anticipated to record an appreciable growth rate over 2020-2025.
 

As per the report findings, USA genome sequencing market size is anticipated to expand at significant pace due to soaring investments in genomics medicine along with increasing partnerships among industry players to accelerate genomics adoption and subsequently lower clinical grade information cost. Moreover, reducing technology cost due to rapid technological innovations are expected boost the industry growth in the coming years.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3114609/
 

Growing necessity of a platform to support deeper sequencing, rising clinical adoption of genome sequencing in rare and undiagnosed genetic diseases, and increasing number of patients with chronic diseases are the other major rationales contributing to USA genome sequencing industry growth. Besides, government funding in R&D activities and establishment genome centers are pushing the industry forward.
 

Further, application of genome sequencing to understand COVID-19 and its spread has augmented the industry growth. The sequencing assists researchers in understanding the efficacy of vaccines and drug on coronavirus.
 

Based on technology, USA genome sequencing market is fragmented into sequencing by synthesis, single-molecule real-time sequencing, sequencing by ligation, ion semiconductor sequencing, chain termination technology, nanopore sequencing, pyrosequencing, and others. Among these, sequencing by synthesis segment is anticipated to showcase robust growth during the forecast period, attributable to wide utilization of the technology in sequencing protocol by many DNA sequencing platforms.
 

Considering the end-user scope, USA genome sequencing market is classified into hospitals & clinics, academic & government research institute, and biotechnology & pharmaceutical companies. Experts claim that academic & government research institute segment held a sizeable portion of the overall industry share in 2019 and is likely to witness modest gains in the coming years. The segment growth can be ascribed to implementation of data analysis in academic and government research institutes for managing a large number of R&D projects.
 

Leading players influencing USA genome sequencing industry trends are Cytiva, Integrated DNA Technologies, Inc., Pacific Biosciences of California, Inc., ThermoFisher Scientific, Inc., Illumina, Inc., Siemens Healthineers AG, PerkinElmer, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche AG, and Abbott Laboratories.